Business
Today: GB Sciences' Use of Controlled Cultivation, Product Formulations and Research Will Be Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on Cover of Cannabis Business Times
Today: GB Sciences' Use of Controlled Cultivation, Product Formulations and Research Will Be Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on Cover of Cannabis Business Times.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nToday: GB Sciences' Use of Controlled Cultivation, Product Formulations and Research Will Be Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on Cover of Cannabis Business Times\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nToday: GB Sciences' Use of Controlled Cultivation, Product Formulations and Research Will Be Presented by Dr. Dominick Monaco at Cannabis Conference 2019, As Featured on Cover of Cannabis Business Times\nPR Newswire\nLAS VEGAS, April 2, 2019\n\n\n\nLAS VEGAS, April 2, 2019 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announced that Dr. Dominick Monaco, GB Sciences' Director of Medical Formulations, will be a featured speaker at the Las Vegas Cannabis Conference TODAY, April 2, at 4:40pm. He will be discussing \"Science That Sells: Debunking the Sativa, Indica Myths & Instead Focusing on Terpenoids, Cannabinoids and Flavonoids.\" Presented by the Cannabis Business Times and Cannabis Dispensary, the conference will bring thousands of cannabis professionals across the country to Las Vegas. Learn more here.\nGB Sciences is located just three miles off the Vegas strip, in a 28,000 square foot state-of-the-art facility featured on the cover of Cannabis Business Times' March 2019 issue. The article also highlights the company's groundbreaking research program, led by Dr. Andrea Small-Howard with the support of Dr. Monaco and our university research partners, who have created a patent portfolio of cannabis-based therapies that covers over 60 disease and health conditions including Parkinson's disease, neuropathic pain, and cardiac hypertrophy. Read the full article here. \n \n\n \nAbout GB Sciences, Inc.GB Sciences, Inc. (OTCQB: GBLX) is a diverse cannabis company, focused on standardized cultivation and production methods; as well as biopharmaceutical research and development. The Company's goal is creating safe, standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. To learn more about GB Sciences, Inc., go to: http://gbsciences.com.\nForward-L...